Table 1.
Demographic and pathologic prognostic indicators of the study participants
| Variable | All Women N= 335 (%) |
African-American N= 100 (%) |
White-American N=235 (%) |
P-Value |
|---|---|---|---|---|
| Age (mean ± SD) | 58 (± 12.5) | 60 (± 13) | 57 (± 12.0) | .017 |
| BMI in Kg/m2 (mean ± SD) | 28.6 (± 6.8) | 30.0 (± 6.6) | 27.8(± 6.8) | .009 |
| Post-menopausal Hormone Therapy | .021 | |||
| Yes | 108 (36.4) | 25 (26.9) | 83 (40.8) | |
| No | 189 (63.6) | 68 (73.1) | 121 (59.2) | |
| Missing | 38 | 7 | 31 | |
| First Degree Family History of Breast Cancer | .44 | |||
| Yes | 75 (25.9) | 25 (28.7) | 50 (24.6) | |
| No | 217(74.1) | 62 (71.3) | 155(75.4) | |
| Missing | 43 | 13 | 30 | |
| Charlson Co-morbidity Index | .010 | |||
| 0 | 268 (83.6) | 74 (75.5) | 194 (87.1) | |
| 1 ≤ | 53 (16.4) | 24 (24.5) | 29 (12.9) | |
| Missing | 14 | 2 | 12 | |
| Clinical Presentation | .073 | |||
| Screening Mammography | 287 (86.2) | 81 (81.0) | 206 (88.4) | |
| Palpation or Nipple Discharge | 46 (13.8) | 19 (19.0) | 27 (11.6) | |
| Missing | 2 | 0 | 2 | |